Literature DB >> 17721613

Extra- and intracellular innate immune recognition in endothelial cells.

Bastian Opitz1, Stefan Hippenstiel, Julia Eitel, Norbert Suttorp.   

Abstract

The innate immune system represents the principal sensor of infections in multicellular organisms and might also mediate responses to some endogenous molecules. In this context, endothelial cells are among the first cells coming into contact with microbial or endogenous (danger-associated) molecules or whole pathogens entering the bloodstream. Since many bacteria and viruses invade the endothelium, endothelial cells are equipped with both extracellular and cytosolic surveillance systems capable of sensing microbial components, and endogenous danger-associated molecules. The receptor molecules, called pattern recognition receptors (PRRs), are classified as transmembrane or cytosolic molecules. While the transmembrane PRRs recognize extracellular and membrane-enclosed foreign organisms, the cytosolic PRRs appear to sense intracellular infections. Here we focus on both PRR classes in general, and outline the current knowledge of extra- and intracellular pattern recognition in endothelial cells and its potential role in vascular diseases and sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721613

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.

Authors:  Hae-Sook Shin; Fengyun Xu; Aranya Bagchi; Elizabeth Herrup; Arun Prakash; Catherine Valentine; Hrishikesh Kulkarni; Kevin Wilhelmsen; Shaw Warren; Judith Hellman
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

Review 2.  Cellular and molecular choreography of neutrophil recruitment to sites of sterile inflammation.

Authors:  Braedon McDonald; Paul Kubes
Journal:  J Mol Med (Berl)       Date:  2011-07-13       Impact factor: 4.599

Review 3.  Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis.

Authors:  Sarah E W Grubb; Craig Murdoch; Peter E Sudbery; Stephen P Saville; Jose L Lopez-Ribot; Martin H Thornhill
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

Review 4.  Inflammation and the blood microvascular system.

Authors:  Jordan S Pober; William C Sessa
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-23       Impact factor: 10.005

Review 5.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

6.  Ischemia/reperfusion Injury and its Consequences on Immunity and Inflammation.

Authors:  Bendix R Slegtenhorst; Frank Jmf Dor; Hector Rodriguez; Floris J Voskuil; Stefan G Tullius
Journal:  Curr Transplant Rep       Date:  2014-09-01

7.  Innate immunity in human embryonic stem cells: comparison with adult human endothelial cells.

Authors:  Gábor Földes; Alexander Liu; Rekha Badiger; Mark Paul-Clark; Laura Moreno; Zsuzsanna Lendvai; Jamie S Wright; Nadire N Ali; Sian E Harding; Jane A Mitchell
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

8.  VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.

Authors:  Xiao-Feng Yang; Ying Yin; Hong Wang
Journal:  Drug Discov Today Ther Strateg       Date:  2008

9.  Inflammasomes are differentially expressed in cardiovascular and other tissues.

Authors:  Y Yin; Y Yan; X Jiang; J Mai; N C Chen; H Wang; X-F Yang
Journal:  Int J Immunopathol Pharmacol       Date:  2009 Apr-Jun       Impact factor: 3.219

Review 10.  Innate immune cell response upon Candida albicans infection.

Authors:  Yulin Qin; Lulu Zhang; Zheng Xu; Jinyu Zhang; Yuan-Ying Jiang; Yongbing Cao; Tianhua Yan
Journal:  Virulence       Date:  2016-04-14       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.